We are live on ! Find out more
FMI

Foundation Medicine, Inc.
FMI

Delisted

FMI was delisted on the 30th of July, 2018.

93 hedge funds and large institutions have $362M invested in Foundation Medicine, Inc. in 2017 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 26 increasing their positions, 34 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

81% more capital invested

Capital invested by funds: $200M → $362M (+$162M)

19% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 16

11% more call options, than puts

Call options by funds: $18.2M | Put options by funds: $16.4M

2% less funds holding

Funds holding: 9593 (-2)

24% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 34

Holders
93
Holders Change
-2
Holders Change %
-2.11%
% of All Funds
2.32%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.1%
New
19
Increased
26
Reduced
34
Closed
16
Calls
$18.2M
Puts
$16.4M
Net Calls
+$1.83M
Net Calls Change
+$2.85M
Name Holding Trade Value Shares
Change
Change in
Stake
GGHC
1
Gilder Gagnon Howe & Co
New York
$52M +$183K +7,347 +0.5%
BlackRock
2
BlackRock
New York
$43.1M +$33.3M +1,334,597 +141,677%
DGI
3
Discovery Group I
Illinois
$42.1M -$7.28M -291,905 -18%
Chevy Chase Trust
4
Chevy Chase Trust
Maryland
$35.4M +$3.85M +154,168 +16%
AllianceBernstein
5
AllianceBernstein
Tennessee
$25.4M +$5.49M +220,236 +39%
OC
6
Oppenheimer & Co
New York
$21.8M -$712K -28,541 -4%
Vanguard Group
7
Vanguard Group
Pennsylvania
$18.8M +$714K +28,619 +5%
CC
8
Casdin Capital
New York
$15.5M -$1.65M -66,000 -12%
AAMU
9
Amundi Asset Management US
Massachusetts
$10.5M +$8.12M +325,642 New
Group One Trading
10
Group One Trading
Illinois
$9.56M +$2.5M +100,353 +51%
AIM
11
ARK Investment Management
Florida
$8.35M -$977K -39,163 -13%
Lord, Abbett & Co
12
Lord, Abbett & Co
New Jersey
$7.59M -$67.8K -2,717 -1%
State Street
13
State Street
Massachusetts
$7.58M +$328K +13,143 +6%
Northern Trust
14
Northern Trust
Illinois
$5.64M +$189K +7,563 +5%
Baillie Gifford & Co
15
Baillie Gifford & Co
United Kingdom
$5.64M
Geode Capital Management
16
Geode Capital Management
Massachusetts
$4.52M +$748K +29,984 +27%
ACM
17
Adalta Capital Management
New York
$4.06M +$3.14M +125,755 New
PIM
18
Platinum Investment Management
Australia
$3.14M -$434K -17,400 -15%
BAMCO Inc
19
BAMCO Inc
New York
$2.83M +$484K +19,400 +28%
Fidelity Investments
20
Fidelity Investments
Massachusetts
$2.82M -$119K -4,788 -5%
Macquarie Group
21
Macquarie Group
Australia
$2.58M
Bank of New York Mellon
22
Bank of New York Mellon
New York
$1.96M +$55.7K +2,232 +4%
NIM
23
Needham Investment Management
New York
$1.85M
Charles Schwab
24
Charles Schwab
California
$1.77M +$68.3K +2,736 +5%
LOAMU
25
Lombard Odier Asset Management (USA)
New York
$1.61M -$977K -39,164 -44%

FMI Hedge Fund Activity: Q1 2017 in Review

93 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Foundation Medicine, Inc. (FMI) for Q1 2017, worth a combined $362M — up 81% from $200M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new FMI positions and 16 closed out — a net gain of 3 holders — while 26 added to existing stakes and 34 trimmed.

The largest buyer was BlackRock, adding an estimated $33.3M. The largest seller was Discovery Group I, cutting an estimated $7.28M.

  • 93 institutional investors held Foundation Medicine, Inc. (FMI) as of Q1 2017, down from 95 in Q4 2016.
  • Funds reported $362M of Foundation Medicine, Inc. stock for Q1 2017, up 81% quarter-over-quarter.
  • 19 funds opened new Foundation Medicine, Inc. positions in Q1 2017 and 16 closed out, a net change of +3 holders.
  • The largest Foundation Medicine, Inc. buyer in Q1 2017 was BlackRock, an estimated $33.3M added.
  • The largest Foundation Medicine, Inc. seller in Q1 2017 was Discovery Group I, an estimated $7.28M sold.

Based on aggregated 13F filings for Q1 2017.